Germany’s Boehringer Ingelheim has opened a new US biopharmaceutical manufacturing facility at Fremont, California, expanding its worldwide bioreactor capacity to 290,000 liters. The US plant, which cost €200 million to build, employs 300 people.
Original Article: Boehringer Expands Biopharmaceuticals in US